Literature DB >> 8910628

Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer.

A Obermair1, P Kohlberger, D Bancher-Todesca, C Tempfer, G Sliutz, S Leodolter, A Reinthaller, C Kainz, G Breitenecker, G Gitsch.   

Abstract

Microvessel density (MVD) and expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF), acting as a highly specific inducer of angiogenesis, were evaluated in tissue specimens of 25 patients with squamous cell cancer of the vulva. MVD was quantified by immunostaining for factor VIII-related antigen at one field of 0.25 mm2. VPF/VEGF expression was evaluated immunohistochemically using a monoclonal anti-VEGF antibody. FIGO stages I, II, and III were diagnosed in 12, 7, and 6 patients, respectively. MVD >20/field was found in 10 of 25 tumors and moderate or strong expression of VPF/VEGF in 10 of 25 tumors. High MVD was significantly more frequent in tumors with moderate or strong VPF/VEGF expression compared to tumors with no or weak VPF/VEGF expression (P = 0.01). Overall survival rates of patients with tumors of high MVD (P = 0.01) and strong VPF/VEGF expression (P < 0.01) were significantly poorer compared to those patients with low MVD or poor VPF/VEGF expression. Strong VPF/VEGF expression and high MVD are considered important parameters of tumor angiogenesis and therefore are related to poor survival probability in vulvar cancer patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910628     DOI: 10.1006/gyno.1996.0307

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  11 in total

Review 1.  Molecular staging of gynecological cancer: What is the future?

Authors:  Pratibha S Binder; Jaime Prat; David G Mutch
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2015-03-04       Impact factor: 5.237

2.  Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma.

Authors:  M A Ghanem; G J van Steenbrugge; M K Sudaryo; R B Mathoera; J M Nijman; Th H van der Kwast
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

Review 3.  Molecular pathways in vulvar squamous cell carcinoma: implications for target therapeutic strategies.

Authors:  Simona Maria Fragomeni; Frediano Inzani; Anna Fagotti; Luigi Della Corte; Stefano Gentileschi; Luca Tagliaferri; Gian Franco Zannoni; Giovanni Scambia; Giorgia Garganese
Journal:  J Cancer Res Clin Oncol       Date:  2020-04-25       Impact factor: 4.553

4.  Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma.

Authors:  Shu Zheng; Ming-Yong Han; Zuo-Xiang Xiao; Jia-Ping Peng; Qi Dong
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

Review 5.  Therapeutic advances in women's cancers.

Authors:  Amy R Carroll; Robert L Coleman; Anil K Sood
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

6.  Angiogenesis in Paget's Disease of the Vulva and the Breast: Correlation with Microvessel Density.

Authors:  Patricia E Ellis; Allan B Maclean; L F Wong Te Fong; Julie C Crow; Christopher W Perrett
Journal:  J Oncol       Date:  2012-03-26       Impact factor: 4.375

7.  Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue.

Authors:  Hedwig P van de Nieuwenhof; Joanne A de Hullu; Johannes H A M Kaanders; Johan Bulten; Leon F A G Massuger; Léon C L T van Kempen
Journal:  Virchows Arch       Date:  2010-10-02       Impact factor: 4.064

8.  Extramammary Paget disease of the vulva: immunohistochemical analysis of neoangiogenesis and epithelial-mesenchymal transition markers expression.

Authors:  Lara Alessandrini; Nicolò Clemente; Tiziana Perin; Giorgio Giorda; Vincenzo Canzonieri; Francesco Sopracordevole
Journal:  Diagn Pathol       Date:  2018-01-03       Impact factor: 2.644

Review 9.  Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?

Authors:  Saikat Mitra; Mashia Subha Lami; Avoy Ghosh; Rajib Das; Trina Ekawati Tallei; Fahadul Islam; Kuldeep Dhama; M Yasmin Begum; Afaf Aldahish; Kumarappan Chidambaram; Talha Bin Emran
Journal:  Cancers (Basel)       Date:  2022-02-01       Impact factor: 6.639

10.  Primary tumor vascularity, HIF-1α and VEGF expression in vulvar squamous cell carcinomas: their relationships with clinicopathological characteristics and prognostic impact.

Authors:  Hari Prasad Dhakal; Jahn M Nesland; Mette Førsund; Claes G Trope; Ruth Holm
Journal:  BMC Cancer       Date:  2013-10-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.